Scinovex
article Open Access

A routine observational study to evaluate the analgesic efficacy of epidural 0.2% ropivacaine in postoperative pain relief

International Journal of Medical Anesthesiology · 2022 · Vol. 5(4) · pp. 07–09

Abstract

Aim: To evaluate the analgesic efficacy of Epidural ropivacaine 0.2% in postoperative pain relief.Method: A routine data based observational study involved 50 patients of ASA1, ASA2 who received Epidural 0.2% Ropivacaine and 50 patients who received Epidural 0.125% bupivacaine postoperatively. All patients were monitored for postoperative pain by the visual analogy scale (VAS), requirement of rescue analgesia, hemodynamic parameters and adverse effects.Results: Postoperative Pain scores, Incidence of hypotension and delayed motor block were comparable between the observational groups.Conclusion: Ropivacaine 0.2% and bupivacaine 0.125% were equally efficient in rescue analgesic requirement, but ropivacaine had a better safety profile in terms of less hypotension and lesser motor block.

Anesthesia and Pain ManagementSpine and Intervertebral Disc PathologyCardiac, Anesthesia and Surgical OutcomesRopivacaineMedicineAnalgesicAnesthesiaObservational studyVisual analogue scaleAdverse effectBupivacaineMotor blockIncidence (geometry)
Citations
0
FWCI
0.00
field-weighted impact
References
0
Percentile
32%
vs. same field & year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.